Israel’s Oravax oral COVID-19 vaccine heads to Southeast Asia The Jerusalem Post

Israel’s oral vaccine is heading to Southeast Asia, Oramed Pharmaceutical announced Wednesday. The company’s subsidiary, Oravax Medical, signed a cooperation and Purchase Agreement with Vietnam-based Tan Thanh Holdings Investment Joint Stock Company to pre-purchase 10 million doses of Oravax’s oral COVID-19 vaccine , currently in development.…

Visit the original:
ChinaPulse.com

Comments are closed.